U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008703) titled 'Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain' on Jan. 28, 2024.
Brief Summary: This is a Phase Ib/IIa, multicenter, sequential clinical trial evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of SSS40 injection in patients with moderate-to-severe bone metastatic cancer pain. The study includes two stages: a single-arm, open-label, dose-escalation and dose-expansion Phase Ib followed by a randomized, double-blind, placebo-controlled Phase IIa.
Study Start Date: March 27, 2024
Study Type: INTERVENTIONAL
Condition:
Cancer Pain
Intervention:
DRUG: Injection o...